Publications (54) FRANCISCO GINER SEGURA publications

2024

  1. A comparison of whole-mount and conventional sections for pathological mesorectal extension and circumferential resection margin assessment after total mesorectal excision

    Cirugia Espanola, Vol. 102, Núm. 8, pp. 417-425

  2. CD34-negative, STAT6-negative, Low-grade, Low-risk Solitary Fibrous Tumor

    American Journal of Surgical Pathology

  3. Primary Papillary Colonic Adenocarcinoma With PDGFRA Mutation. A New Morphological Subtype? A Case Report and Review of Literature

    International Journal of Surgical Pathology

  4. Solitary fibrous tumor: Can the new Huang risk stratification system for orbital tumors improve prognostic accuracy in other tumor locations?

    Pathology Research and Practice, Vol. 254

  5. The Combined Immunohistochemical Expression of GLI1 and BCOR in Synovial Sarcomas for the Identification of Three Risk Groups and Their Prognostic Outcomes: A Study of 52 Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 14

  6. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms

    Virchows Archiv, Vol. 484, Núm. 5, pp. 765-775

2023

  1. Evaluation of Alternative Risk Stratification Systems in a Large Series of Solitary Fibrous Tumors with Molecular Findings and Ki-67 Index Data: Do They Improve Risk Assessment?

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  2. Extra-meningeal solitary fibrous tumor: an evolving entity with chameleonic morphological diversity, a hallmark molecular alteration and unresolved issues in risk stratification assessment

    Histology and histopathology, Vol. 38, Núm. 10, pp. 1079-1097

  3. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome — an immunohistochemical and molecular analysis of 31 cases

    Virchows Archiv, Vol. 482, Núm. 2, pp. 407-417

  4. How to Know if a D3 Lymphadenectomy Has Been Actually Performed in a Right Hemicolectomy: Focus on the Pathology Report

    Diseases of the colon and rectum, Vol. 66, Núm. 2, pp. e51-e52

  5. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  6. The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer

    Colorectal Disease, Vol. 25, Núm. 6, pp. 1135-1143

  7. Tumor Microenvironment and Its Clinicopathologic and Prognostic Association in Cutaneous and Noncutaneous Angiosarcomas

    American journal of clinical pathology, Vol. 160, Núm. 1, pp. 18-34

2022

  1. Early colorectal cancer diagnosed after endoscopic resection: Conservative treatment is safe in most of the cases. Proposal for a risk-based management

    Cirugia Espanola, Vol. 100, Núm. 10, pp. 635-640

  2. Opioid Receptor Expression in Colorectal Cancer: A Nested Matched Case-Control Study

    Frontiers in Oncology, Vol. 12

  3. The Effect of Lipofilling and Platelet-Rich Plasma on Patients with Moderate-Severe Vulvar Lichen Sclerosus who were Non-Responders to Topical Clobetasol Propionate: A Randomized Pilot Study

    Aesthetic plastic surgery, Vol. 46, Núm. 5, pp. 2469-2479

2021

  1. Angiosarcomas: Histology, immunohistochemistry and molecular insights with implications for differential diagnosis

    Histology and Histopathology, Vol. 36, Núm. 1, pp. 3-18

  2. Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study

    Pathology Research and Practice, Vol. 225

  3. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?

    Pathology Research and Practice, Vol. 219

  4. Solitary fibrous tumor: Integration of clinical, morphologic, immunohistochemical and molecular findings in risk stratification and classification may better predict patient outcome

    International Journal of Molecular Sciences, Vol. 22, Núm. 17